Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Aldeyra Therapeu (ALDX)

Aldeyra Therapeu (ALDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 435,673
  • Shares Outstanding, K 58,323
  • Annual Sales, $ 0 K
  • Annual Income, $ -57,780 K
  • 60-Month Beta 1.43
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.50
Trade ALDX with:

Options Overview Details

View History
  • Implied Volatility 106.78% ( +3.51%)
  • Historical Volatility 83.78%
  • IV Percentile 43%
  • IV Rank 16.17%
  • IV High 295.53% on 06/17/22
  • IV Low 70.36% on 04/25/22
  • Put/Call Vol Ratio 0.38
  • Today's Volume 305
  • Volume Avg (30-Day) 523
  • Put/Call OI Ratio 0.23
  • Today's Open Interest 15,899
  • Open Int (30-Day) 13,155

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.33
  • Number of Estimates 4
  • High Estimate -0.27
  • Low Estimate -0.41
  • Prior Year -0.27
  • Growth Rate Est. (year over year) -22.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.66 +60.13%
on 07/15/22
7.99 -6.51%
on 08/10/22
+2.33 (+45.33%)
since 07/12/22
3-Month
2.36 +216.53%
on 05/19/22
7.99 -6.51%
on 08/10/22
+5.04 (+207.41%)
since 05/12/22
52-Week
2.36 +217.20%
on 05/12/22
9.81 -23.85%
on 09/02/21
-2.13 (-22.19%)
since 08/12/21

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Aldeyra Therapeutics, Inc. is a biotechnology company. The company's products target immune-mediated, inflammatory, orphan, and other diseases. It is developing NS2, a compound that binds and traps free aldehydes. Aldeyra Therapeutics, Inc. is based in Burlington, Massachusetts.

See More

Key Turning Points

3rd Resistance Point 8.11
2nd Resistance Point 7.86
1st Resistance Point 7.66
Last Price 7.47
1st Support Level 7.21
2nd Support Level 6.96
3rd Support Level 6.76

See More

52-Week High 9.81
Last Price 7.47
Fibonacci 61.8% 6.96
Fibonacci 50% 6.08
Fibonacci 38.2% 5.20
52-Week Low 2.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar